Eléments de l'association

	C. Szczylik	2
	Anticancéreux	231
	C. Szczylik *Sauf* Anticancéreux"	0
	Anticancéreux *Sauf* C. Szczylik"	229
	C. Szczylik Et Anticancéreux	2
	C. Szczylik Ou Anticancéreux	231
	*Corpus*	11069

List of bibliographic references

Number of relevant bibliographic references: 2.

Ident.	Authors (with country if any)	Title
002731	D. Cunningham [Royaume-Uni] ; B. Sirohi [Royaume-Uni] ; A. Pluzanska [Pologne] ; B. Utracka-Hutka [Pologne] ; J. Zaluski [Pologne] ; R. Glynne-Jones [Royaume-Uni] ; P. Koralewski [Pologne] ; J. Bridgewater [Royaume-Uni] ; P. Mainwaring [Australie] ; H. Wasan [Royaume-Uni] ; J.-Y. Wang [Taïwan] ; C. Szczylik [Pologne] ; P. Clingan [Australie] ; R. T. T. Chan [Hong Kong] ; I. Tabah-Fisch [France] ; J. Cassidy [Royaume-Uni]	Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer
003228	B. Melichar [République tchèque] ; P. Koralewski [Pologne] ; A. Ravaud [France] ; A. Pluzanska [Pologne] ; S. Bracarda [Italie] ; C. Szczylik [Pologne] ; C. Chevreau [France] ; M. Filipek [Pologne] ; R. Delva [France] ; E. Sevin [France] ; S. Negrier [France] ; J. Mckendrick [Australie] ; A. Santoro [Italie] ; P. Pisa [Suisse] ; B. Escudier [France]	First-line bevacizumab combined with reduced dose interferon-a2a is active in patients with metastatic renal cell carcinoma

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024